Task Order Supplement to A5267
Investigator: Diane Havlir, MD
Sponsor: Social & Scientific Systems, Inc.
Location(s): United States
Safety, Tolerability & PK Interaction Study of TMC207 & Efavirenz
Phase I, prospective, open-label, limited-center pharmacokinetic (PK) interaction study designed to compare the PK of TMC207 given alone with the PK of TMC207 given concomitantly with EFV and to evaluate the safety and tolerability of TMC207 given together with EFV. This protocol completed enrollment and follow-up in December 2010.